These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18628982)

  • 21. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
    Marson A; Kretschmer K; Frampton GM; Jacobsen ES; Polansky JK; MacIsaac KD; Levine SS; Fraenkel E; von Boehmer H; Young RA
    Nature; 2007 Feb; 445(7130):931-5. PubMed ID: 17237765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors.
    Vermeersch E; Liénart S; Collignon A; Lucas S; Gallimore A; Gysemans C; Unutmaz D; Vanhoorelbeke K; De Meyer SF; Maes W; Deckmyn H
    Cell Immunol; 2018 Oct; 332():129-133. PubMed ID: 30093071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.
    Schmidt A; Oberle N; Weiss EM; Vobis D; Frischbutter S; Baumgrass R; Falk CS; Haag M; Brügger B; Lin H; Mayr GW; Reichardt P; Gunzer M; Suri-Payer E; Krammer PH
    Sci Signal; 2011 Dec; 4(204):ra90. PubMed ID: 22375050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.
    Ono M
    Immunology; 2020 May; 160(1):24-37. PubMed ID: 32022254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive IL-17A
    Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
    Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Tregs' world according to GARP.
    Battaglia M; Roncarolo MG
    Eur J Immunol; 2009 Dec; 39(12):3296-300. PubMed ID: 19904770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.
    Haxhinasto S; Mathis D; Benoist C
    J Exp Med; 2008 Mar; 205(3):565-74. PubMed ID: 18283119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human LAP
    Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
    Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YY1 inhibits differentiation and function of regulatory T cells by blocking Foxp3 expression and activity.
    Hwang SS; Jang SW; Kim MK; Kim LK; Kim BS; Kim HS; Kim K; Lee W; Flavell RA; Lee GR
    Nat Commun; 2016 Feb; 7():10789. PubMed ID: 26892542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.
    Huygens C; Liénart S; Dedobbeleer O; Stockis J; Gauthy E; Coulie PG; Lucas S
    J Biol Chem; 2015 Aug; 290(33):20105-16. PubMed ID: 26126825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated receptor for activated C kinase 1 expression is involved in intracellular Ca2+ influx and potentially associated with compromised regulatory T cell function in patients with asthma.
    Negoro T; Shimizu S; Narushima M; Banham AH; Wakabayashi H; Takayanagi R; Hagiwara T; Roncador G; Osabe T; Yanai T; Kin M; Ikeda K; Endo A; Akiyama H; Nakano Y
    Clin Exp Allergy; 2014 Sep; 44(9):1154-69. PubMed ID: 25048599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response.
    Sun L; Wu J; Yi S
    Transpl Immunol; 2012 Mar; 26(2-3):71-80. PubMed ID: 22079196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
    Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
    Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.